+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
Crohn's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Crohn's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Rhinosinusitis - Pipeline Insight, 2025 - Product Thumbnail Image

Rhinosinusitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Diabetic Retinopathy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Diabetic Retinopathy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 185 Pages
  • Global
From
From
From
Drug Discovery Services Market Report 2026 - Product Thumbnail Image

Drug Discovery Services Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026 - Product Thumbnail Image

Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026

  • Report
  • October 2021
  • 210 Pages
  • Global
From
From
Neurofibromatosis Treatment Market Report 2026 - Product Thumbnail Image

Neurofibromatosis Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Catalepsy Treatment Market Report 2026 - Product Thumbnail Image

Catalepsy Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator